Conference Proceedings
Ongoing clinical trial: PESTO, a prospective multicenter, phase 2b randomized controlled double-blind trial, to determine the safety and efficacy of perispinal etanercept on quality of life at 28 days post treatment
V Thijs, J Bernhardt, L Churilov, N Sprigg, G Cloud, B Parsons, S Jafari, M Walker, N Gilchrist, P Bath
INTERNATIONAL JOURNAL OF STROKE | SAGE PUBLICATIONS LTD | Published : 2021